| Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
  | hyperparathyroidism | MEN1* | Men1* | 1 model | Alliance of Genome Resources | ||
| hyperparathyroidism | CASR* | Casr* | 6 models | Alliance of Genome Resources | |||
| hyperparathyroidism | CDC73* | Cdc73* | 3 models | Alliance of Genome Resources | |||
| | hyperparathyroidism | GCM2* | Gcm2 | Alliance of Genome Resources | |||
| hyperparathyroidism | TRPV6* | Trpv6 | Alliance of Genome Resources | ||||
| primary hyperparathyroidism | MIR30E* | Mir30e | Alliance of Genome Resources | ||||
| primary hyperparathyroidism | VDR* | Vdr | Alliance of Genome Resources | ||||
| secondary hyperparathyroidism | CASR* | Casr | Alliance of Genome Resources | ||||
| secondary hyperparathyroidism | PTH* | Pth | Alliance of Genome Resources | ||||
Excel File
|
Transgenes and other genome features developed in mice to model this disease.
|
|||
| Disease Term | Transgenes and Other Genome Features | Mouse Models | |
| primary hyperparathyroidism | Tg(PTH-CCND1)PC2Anar | 1 model | |